ANTI-TUMOUR COMPOSITION Russian patent published in 2022 - IPC C12N15/86 C12N15/113 C07K14/54 A61K38/20 A61K48/00 A61P35/00 

Abstract RU 2768287 C1

FIELD: biotechnology.

SUBSTANCE: described is a group of inventions including an adenovirus system for treating cancer, an anti-cancer composition including the above adenovirus system, and a composition for enhancing the anti-tumour immunity including the above adenovirus system. In one of the implementations, the adenovirus system contains a gene encoding interleukin-12 (IL-12); and a gene expressing an oligonucleotide complementary to C-met (Met tyrosine kinase) mRNA and inhibits C-met expression.

EFFECT: invention expands the range of anticancer products.

15 cl, 22 dwg, 2 tbl, 16 ex

Similar patents RU2768287C1

Title Year Author Number
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT 2012
  • Li, Sang Dzin
  • Kim,Jun Khee,
  • Kim,In Khoo
  • Choi,Kiung Kho
  • Chun,Kiung-Khee
RU2575620C2
ANTICANCER COMPOSITION CONTAINING TUMOR-SPECIFIC ONCOLYTIC ADENO VIRUS AND INHIBITOR OF CONTROL POINT OF IMMUNE RESPONSE 2018
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2777523C2
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS 2009
  • Khemminki Akseli
  • Kanerva Anna
  • Cherullo Vinchentso
  • Pesonen Sari
RU2520823C2
ANTICANCER COMPOSITION CONTAINING A TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND AN IMMUNE RESPONSE CONTROL POINT INHIBITOR 2018
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2740713C1
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX 2017
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2742726C2
ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT 2010
  • Gedan Karrio Sonija
  • Kaskal'O Pikeras Manel' Marija
  • Alemani Bonastre Ramon
RU2536931C2
ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE 2015
  • Alemany Bonastre, Ramon
  • Rojas Exposito, Luis Alfonso
RU2711371C2
COMBINATION THERAPY USING REIC/DKK-3 GENE AND IMMUNE RESPONSE CHECKPOINT INHIBITOR 2017
  • Kumon Hiromi
  • Lowenthal Richard
RU2767997C2
DESIGNING OF CARCINOLYTIC ADENOVIRUS RECOMBINANT, SPECIFICALLY EXPRESSING IMMUNOMODULATORY FACTOR GM-CSF IN TUMORAL CELLS AND ITS APPLICATION 2004
  • Ke Zunkhond
RU2361611C2
VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF 2011
RU2612788C2

RU 2 768 287 C1

Authors

Yun, Chae Ok

Oh, Eon Ju

Dates

2022-03-23Published

2019-07-10Filed